Comparative in vitro activity of cefdinir (CI-983; FK-482) against staphylococci, gram-negative bacilli and respiratory tract pathogens
- 1 July 1992
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 11 (7), 646-652
- https://doi.org/10.1007/bf01961677
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393): A novel orally administered cephalosporinDiagnostic Microbiology and Infectious Disease, 1991
- The in-vitro activity of cefdinir (FK482), a new oral cephalosporinJournal of Antimicrobial Chemotherapy, 1991
- Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporinAntimicrobial Agents and Chemotherapy, 1989
- Pharmacokinetics of FK482, a new orally active cephalosporin, in animals.The Journal of Antibiotics, 1988
- In vitro antibacterial activity of FK482, a new orally active cephalosporin.The Journal of Antibiotics, 1988
- FK 482, a new orally active cephalosporin. Synthesis and biological properties.The Journal of Antibiotics, 1988